December 04, 2025
Roughly 5.1% of U.S. adults may now be using GLP-1 agonists to try to control their weight, according to <a href="https://news.ehealthinsurance.com/" target="_blank" link-data="{"cms.site.owner":{"_ref":"0000018e-8611-dbad-a9af-fe79f4ec0000","_type":"ae3387cc-b875-31b7-b82d-63fd8d758c20"},"cms.content.publishDate":1764830989726,"cms.content.publishUser":{"_ref":"00000192-f502-d200-a19b-fd17f90c0000","_type":"6aa69ae1-35be-30dc-87e9-410da9e1cdcc"},"cms.content.updateDate":1764830989726,"cms.content.updateUser":{"_ref":"00000192-f502-d200-a19b-fd17f90c0000","_type":"6aa69ae1-35be-30dc-87e9-410da9e1cdcc"},"link":{"attributes":[],"target":"NEW","url":"https://news.ehealthinsurance.com/","_id":"0000019a-e81f-d61b-a3be-ebdf96590000","_type":"33ac701a-72c1-316a-a3a5-13918cf384df"},"theme.bundle-default.:link:LinkEnhancement.hbs._template":null,"theme.bundle-default.:link:LinkEnhancement.hbs._preset":null,"_id":"0000019a-e81f-d61b-a3be-ebdf96590001","_type":"02ec1f82-5e56-3b8c-af6e-6fc7c8772266"}">eHealth</a>.
